Albemarle Corp ALB
We take great care to ensure that the data presented and summarized in this overview for ALBEMARLE CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ALB
View all-
Vanguard Group Inc Valley Forge, PA14.6MShares$1.12 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA10.2MShares$784 Million0.14% of portfolio
-
Black Rock Inc. New York, NY9.96MShares$767 Million0.02% of portfolio
-
State Street Corp Boston, MA6.52MShares$502 Million0.02% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.48MShares$499 Million0.12% of portfolio
-
Primecap Management CO Pasadena, CA3.35MShares$258 Million0.23% of portfolio
-
Geode Capital Management, LLC Boston, MA2.8MShares$215 Million0.02% of portfolio
-
Franklin Resources Inc San Mateo, CA2.6MShares$200 Million0.07% of portfolio
-
Ubs Group Ag2.44MShares$188 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.14MShares$165 Million0.01% of portfolio
Latest Institutional Activity in ALB
Top Purchases
Top Sells
About ALB
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Insider Transactions at ALB
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 27
2025
|
J Kent Masters Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,442
-6.1%
|
$580,476
$78.97 P/Share
|
Feb 27
2025
|
J Kent Masters Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,932
+12.18%
|
-
|
Feb 27
2025
|
Netha N. Johnson Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,019
-2.36%
|
$79,482
$78.97 P/Share
|
Feb 27
2025
|
Netha N. Johnson Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,518
+7.54%
|
-
|
Feb 27
2025
|
Eric Norris Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,019
-2.14%
|
$79,482
$78.97 P/Share
|
Feb 27
2025
|
Eric Norris Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,518
+6.88%
|
-
|
Feb 27
2025
|
Melissa H. Anderson Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
830
-6.3%
|
$64,740
$78.97 P/Share
|
Feb 27
2025
|
Melissa H. Anderson Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,866
+17.86%
|
-
|
Feb 27
2025
|
Mark Richard Mummert Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
150
-2.12%
|
$11,700
$78.97 P/Share
|
Feb 27
2025
|
Mark Richard Mummert Chief Supply Chain Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
522
+6.86%
|
-
|
Feb 27
2025
|
Donald J. La Bauve Jr. VP, Corporate Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-2.81%
|
$11,934
$78.97 P/Share
|
Feb 27
2025
|
Donald J. La Bauve Jr. VP, Corporate Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
522
+8.75%
|
-
|
Feb 26
2025
|
Netha N. Johnson Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-0.64%
|
$19,558
$77.53 P/Share
|
Feb 26
2025
|
Eric Norris Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-0.57%
|
$19,558
$77.53 P/Share
|
Feb 26
2025
|
Melissa H. Anderson Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-1.65%
|
$13,321
$77.53 P/Share
|
Feb 26
2025
|
Mark Richard Mummert Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-1.56%
|
$8,008
$77.53 P/Share
|
Feb 26
2025
|
Donald J. La Bauve Jr. VP, Corporate Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
110
-2.18%
|
$8,470
$77.53 P/Share
|
Feb 25
2025
|
Mark Richard Mummert Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-2.61%
|
$13,962
$78.42 P/Share
|
Feb 25
2025
|
Melissa H. Anderson Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
414
-4.02%
|
$32,292
$78.42 P/Share
|
Feb 25
2025
|
Eric Norris Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-1.16%
|
$39,780
$78.42 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 14.1K shares |
---|---|
Exercise of conversion of derivative security | 35K shares |
Payment of exercise price or tax liability | 16.4K shares |
---|---|
Other acquisition or disposition | 3.72K shares |
Open market or private sale | 5.9K shares |